Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Levered Free Cash Flow (FCF)

Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Levered Free Cash Flow (FCF) from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-39m a 62.21% decrease of -24m year over year
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the last 12 months ending December 12, 2018 was $-92m a 70.27% decrease of -65m year over year
  • Apellis Pharmaceuticals Inc Annual Levered Free Cash Flow (FCF) for 2018 was $-92m a 70.27% decrease of -65m from 2017
  • Apellis Pharmaceuticals Inc Annual Levered Free Cash Flow (FCF) for 2017 was $-27m a 41.42% decrease of -11m from 2016
  • Apellis Pharmaceuticals Inc Annual Levered Free Cash Flow (FCF) for 2016 was $-16m a 29.33% decrease of -5m from 2015
Other Cash Flow Metrics:
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-44m a 48.43% decrease of -22m year over year
View Chart On Koyfin

Quarterly APLS Levered Free Cash Flow (FCF) Data

12/2018$-39m
09/2018$-22m
06/2018$-21m
03/2018$-15m
12/2017$-14m
09/2017$-8m

Annual APLS Levered Free Cash Flow (FCF) Data

2018$-92m
2017$-27m
2016$-16m
2015$-11m